Concord Biotech IPO — Listing Performance
Concord Biotech IPO facts & figures
| Issue category | Mainboard |
|---|---|
| Issue open date | 4 Aug 2023 |
| Listing date | 18 Aug 2023 |
| Issue price | ₹741 |
| Listing-day close | ₹942.80 (27.23%) |
| Recent market price | ₹1,505.70 (103.2% vs issue) |
| 52-week range | ₹961.30 – ₹1,698.90 |
| Identifiers | NSE: CONCORDBIO · ISIN: INE338H01029 |
How the listing went
Concord Biotech had a strong market debut, ending listing day 27.23% over the issue price.
Concord Biotech against every other debut on record
- Rank in 2023: 74 of 172 NSE debuts, on a 27.23% first-day close.
- 58th percentile of 56 mainboard debuts in 2023 (median 21.06%).
- 9th of 16 debuts in August 2023.
- Opened 21.46% above issue, then added 5.77 points to the close.
- Day-one range ₹900.05 to ₹987.70: a 11.83% swing on the issue price.
- Last close ₹1,505.70 (11 Sep 2026): 103.2% above issue, against 27.23% on day one.
- 74% up its 52-week range of ₹961.30 to ₹1,698.90.
- Priced at the top of the ₹705 to ₹741 band.
- Listed 10 calendar days after close.
- All 508 mainboard debuts on record: median 12.01%, 72% closed above issue.
Computed over 1109 verified NSE debuts to 11 Sep 2026 · sources